Illustration (AI-generated)
The White House on Tuesday withdrew Dr. Heidi Overton’s nomination to lead the Food and Drug Administration, a day before a Senate committee was set to vote on her.
“FDA nominee Heidi Overton lacks the support on the Hill to move forward with her confirmation,” a senior administration official told Axios, which first reported the decision late Tuesday.
“We need to go in a new direction at FDA, and everybody fully supports Secretary Kennedy’s vision to Make America Healthy Again,” the official added, referring to Health and Human Services Secretary Robert F. Kennedy Jr.
Overton, a physician and deputy director of the White House Domestic Policy Council, was nominated in August. She has spent most of her career working for President Donald Trump or allied conservative groups, the Associated Press reported.
She needed all 12 Republicans on the Senate Health, Education, Labor and Pensions Committee, where Democrats hold 11 seats. Without the panel’s backing, she had little chance on the floor, The Guardian noted.
The committee’s chairman, Sen. Bill Cassidy, a Louisiana Republican and physician, said Tuesday he remained undecided. He had called her support for Trump’s plan to split up combination childhood vaccines “almost disqualifying.”
That plan includes breaking the measles, mumps and rubella shot into three separate jabs. The withdrawal came days after the United States lost its measles-elimination status.
Overton appeared with Trump in August as he touted an executive order to cut the number of recommended childhood vaccinations, which unnerved medical groups and career FDA officials, according to people familiar with the matter cited by CNBC, which relayed Reuters reporting.
Pressure also came from Trump’s own coalition. Some Make America Healthy Again activists saw her as siding with health and agriculture interests, while anti-abortion groups questioned her commitment to tightening rules on the abortion pill mifepristone.
Democrats, meanwhile, opposed her as an abortion opponent. In a 2023 policy brief, she urged Congress to strictly regulate mifepristone and criticized policies allowing the pills to be mailed.
Mini Timmaraju, president of Reproductive Freedom for All, celebrated the withdrawal and said her members “kept the pressure on to tank her confirmation.”
Overton also drew fire for defending the FDA’s May authorization of fruit-flavored vapes, which she said could help some adults quit smoking. One advocacy group papered Washington with posters branding her “Heidi Vaperton.”
Republican losses in the Nov. 3 midterms complicated the math. Cassidy, Sen. Susan Collins of Maine and Sen. Roger Marshall of Kansas, all committee members, lost their reelection bids.
Two people told Reuters the White House is weighing Marshall, a former obstetrician, as a replacement. Republicans are racing to confirm nominees before Democrats take control of the Senate in January.
The FDA has been run by acting Commissioner Kyle Diamantas since Commissioner Marty Makary resigned in May. The agency has lost more than 4,500 staff over the past year.
Content created by Conservative Daily News and some content syndicated through CDN is available for re-publication without charge under the Creative Commons license. Visit our syndication page for details and requirements.
Chinese President Xi Jinping personally welcomed President Trump to Shenzhen for the APEC summit, a…
Our homes are well-accessorized with glass from windowpanes to shower doors to tabletops to lovely…
Federal Reserve Governor Lisa Cook's lawyer told the White House she has no obligation to…
Democrat Mary Peltola defeated Republican Sen. Dan Sullivan in Alaska, the Associated Press projected, closing…